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EDITORIAL
Dear Colleagues
As 2018 reaches its end it seems appropriate to reflect on 
what our Journal has achieved and also, what it did not, this 
year. This reflection should not overlook the hard and often 
grinding contribution the Journal’s staff made. However, in 
acknowledging the valuable academic input by a small cohort 
(the great majority are volunteers) the Journal should continue 
to strive for improvement. This improvement (within its austere 
imposition of limited resources) is unlikely to be dramatic but it 
can and should be incrementally relevant. 
The Journal represents a small society of endocrinologists from a 
small country situated in a large continent beset with even larger 
challenges including those enormous ones that determine poor 
health outcomes. As such, the Journal should offer new (and 
also not so new) knowledge that may result in better and more 
direct health and patient outcome. It should also focus on major 
disease burdens if ownership of new and major health policy 
directives (refer to the NHI implementation in SA) is to reflect 
rational clinical and academic input. Lastly, the Journal should 
be both medically and socially transformative – this imperative 
should importantly not only consider the broader society of 
citizens whose health it seeks to promote, but also address 
equity and opportunity within its own constituencies. 
This November issue features three international and three local 
submissions. These include four articles that address various 
aspects of diabetes (an emerging world epidemic), related 
care and outcomes, an analysis of post-treatment outcomes in 
patients with acromegaly and last but not least, a sober audit of 
clinical and academic representation (unequal by all accounts) 
by endocrinologists who happen to be women.    
Mukona D and colleagues highlight the adverse impact of poor 
adherence (average of only 66%) to glucose-lowering therapies 
in Zimbabwe as reflected by poor maternal and neonatal 
outcomes.  They reinforce the need to achieve glucose control 
in pregnant mothers with diabetes. Diabetic macular oedema 
is a common complication and contributes to significant visual 
impairment in patients. Cavdari C et al provide real life options of 
utilising intra-vitreal vascular endothelial growth factor inhibitors 
to improve visual performance. This Turkish study highlights 
both the efficacy and the challenges inherent in such chronic 
therapy.  Siddique M et al provide an option of reducing HbAic 
levels significantly with exercise intervention gauged objectively 
by pedometry (mean daily step counting) – a pragmatic, simple 
and economic lifestyle intervention appropriate for patients in 
Johannesburg?  The frequency of hypoglycaemia remains a 
major limitation to intensive insulin replacement in patients with 
Type 1 diabetes striving to attain normoglycaemia.  Continuous 
or intermittent (flash) glucose monitoring devices no doubt can 
contribute to equal or improved HbAic levels with attendant less 
hypoglycaemia. This engaging (well informed and motivated 
patient required) and expensive (sustained funder acquiesence) 
option is comprehensively reviewed by Distiller L.  Abdurrarouf M 
and colleagues provide a retrospective analysis of the outcome of 
primary pituitary surgery for acromegaly. The Durban experience 
reveals the challenges of attaining comparative cure rates in 
the setting of advanced disease and resource constraints in the 
developing setting. Finally Elhakimi W and colleagues remind us 
from Madina in Saudi Arabia that women only account for 28% of 
authorship in major endocrinology journals despite accounting 
for some 75% of worldwide endocrinology fellowships. Either 
women somehow lose their skills in research and publishing data 
or some major transformative agenda in clinical and academic 
endocrinology is indicated. Perhaps SEMDSA and JEMDSA may 
take the initial steps and offer world leadership in this regard!
A prosperous 2019 and merry Xmas or better, Mary Xmas.
Jeffrey  Wing
